EU double standards threaten to leave poor countries without medicines
New report by Oxfam International and Health Action International Europe.
The European Union is contradicting world trade rules by putting the interests of big drug companies before the 2 billion people in the world who cannot access essential medicines, according to a new report issued today by Oxfam International and Health Action International Europe.
The EU’s actions also undermine its obligations to achieve the Millennium Development Goals, as well as World Trade Organization agreements.
The report coincides with recent news that India and Brazil are filing a complaint against the European Commission at the WTO after the Netherlands seized anti-HIV and other medicines earlier this year. The medicines were going from India via Europe to Brazil, Colombia and Nigeria.
The report says that, since late 2008, Germany as well as the Netherlands has made customs seizures together totaling 19 shipments of generic medicines bound for developing countries. Oxfam and HAI (Europe) say the generic shipments were legitimate under WTO rules.
The EU is increasing pressure on developing country governments to surrender their rights to obtain affordable, generic medicines in order to protect public health, even though these rights are guaranteed under global trade rules, the groups say.
The EU is also insisting on tough new intellectual property rules in bilateral free trade deals that go beyond the WTO’s existing TRIPS agreement.
The EU is pushing these measures that will result in higher medicine prices in developing countries at the same time it is trying to reduce domestic medicine prices. Twenty-four out of 27 EU Member States have taken steps to implement price controls for medicines.
Furthermore, the European Commission is carrying out a high profile investigation into the pharmaceutical industry for intellectual property abuses in the European Union, and is contemplating action against these companies.
Elise Ford, Oxfam head of EU advocacy, said: “The EU is guilty of double standards. One rule for the rich and another for the poor. A crackdown on European pharmaceutical prices is happening alongside a concerted effort to further push intellectual property rules that prevent poor countries from buying affordable medicines.
The EU’s policies are increasing the cost of medicines. This is hitting the poorest people in developing countries disproportionately hard, as 20-60% of their health budgets are spent on medicines.
“Millions of poor people have to pay for medicines out of their own pockets so even a small price rise can make them unaffordable. Europe’s policies are directly responsible for this scandal,” Ford said.
The EU’s trade policies demand that developing countries protect the interests of drug companies above public health priorities, and the EU demands exceed even those made by the much-criticized US administration of President Bush.
Sophie Bloemen, Projects Officer for Health Action International Europe, said: “The EU must accept its moral and legal obligations. There is growing evidence that the EU’s trade agenda is causing severe damage to public health in developing countries.”
The report details a number of other EU policies that are damaging access to medicines in developing countries including:
- promotion of a new global framework to enforce Intellectual Property rules which delay access to generic medicines in developing countries, including through seizures of legitimate medicines;
- obstructing progress at the World Health Organization towards new models of research and development that meet health needs in developing countries;
- and spending on R&D for developing countries that remains insufficient in spite of increases in recent years.
These policies lack coherence and undermine broader EU development objectives to promote access to health care. While the EU is increasing funding to improve health care for European citizens, it is denying developing countries the affordable medicines they need to ensure good health, the report says.
“It’s time that the EU joins up its policies. Both the EC and Member States must promote access to health care in their development policies and access to affordable medicines through their trade policy,” Ford said.
Notes to Editors
- The TRIPS (Agreement on Trade Related Aspects of Intellectual Property Rights) global patent system restricts the availability of low-cost generic medicines but has failed to speed up to the development of new medicines for poor countries.
- The TRIPS Agreement and the Doha Declaration on TRIPS and Public Health (2001) gives governments the right to use legal safeguards and flexibilities to prioritize public health over the enforcement of intellectual property rules.
- Least-developed countries have until 2016 to fully implement TRIPS.
European Union Office reports and papers
Risky jobs & domestic violence = the social cost of today’s high #foodprices http://t.co/UFZRYFYWqi new Oxfam & @IDS_UK report1 hour 35 min ago
+32 million people fled their homes last yr because of #climate disasters such as floods, storms, earthquakes http://t.co/CumgcyOrWK2 hours 4 min ago
Africa must be in control of its fortune - and therefore it's future http://t.co/kMnJFIQmQu @Winnie_Byanyima via @allafrica14 hours 15 min ago
As summer temps could reach +100°F, health risks increase for #Syria #refugees in Jordan & Lebanon http://t.co/Zhzv5FT8he #SyriaCrisis16 hours 28 min ago
Number of Syrians in need of humanitarian aid rises to over 8 million http://t.co/uYHZbeHonP via @UN @Refugees #SyriaCrisis16 hours 54 min ago
RT @benphillips76: Oxfam's Pan Africa @JanahNcube: "Our leaders say we are rising. They are rising but inequality is obscene. Stealing is n…17 hours 41 min ago
In #Kenya, women own 1/2 of all small & medium enterprises, but lack comparable support/resources that men receive http://t.co/1JscJYHCZJ18 hours 35 min ago
Cameron: #G8 will 'knock down the wall of secrecy' on UK-linked #taxhavens. Will he make good? http://t.co/NjorjQpqAk @HuffPostUK19 hours 35 min ago
RT @OxfamEAfrica: "3 bombs fell in one of the camps. Refugees are fleeing." @Oxfam's Eddy Mbuyi on new #Goma fighting http://t.co/ygE0OnshU…20 hours 4 min ago
#Resilience is the new #globaldev buzzword. So how can we reduce #inequality & make people less vulnerable? http://t.co/HIRCgQ68eW #post201520 hours 41 min ago
We welcome @WorldBank support for removal of user fees, a major barrier to achieving Universal Health Coverage http://t.co/16paFMiifN #UHC21 hours 14 min ago
RT @louis_press: Report (in Arabic) on a great org helping Syrian refugees living in cemetery. On @AlArabiya w @ai_eman @Oxfam #syria http:…21 hours 38 min ago
21 hours 46 min ago
We're providing humanitarian aid in #Somalia via an innovative e-cash program http://t.co/AtzoQZzIsO #m4d22 hours 35 min ago
Ending #taxdodging in #India could feed all hungry people there. And much more. http://t.co/K6M6PlZ3ne23 hours 7 min ago